CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study - Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed; Benner, Axel; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Fenk, Roland; Munder, Markus; Dürig, Jan; Blau, Igor W.; Huhn, Stefanie; et al. (Leukemia, 2024)
Online veröffentlicht: 3. Juni 2024